Fact-checked by Grok 2 weeks ago

Serous membrane

A serous membrane, also known as a serosa, is a thin, double-layered structure composed of a called overlying a layer of , which lines specific closed body cavities and envelops the organs contained within them. This membrane secretes a watery that fills the between its layers, providing lubrication to minimize friction during organ movement. The serous membrane consists of two distinct layers: the parietal layer, which adheres to the walls of the , and the visceral layer, which directly covers the surface of the enclosed s. These layers are continuous, forming a closed sac around the organs, and the between them—typically 20–60 mL in volumes such as the pericardial cavity—facilitates smooth gliding motions while also acting as a barrier against and . Key functions include reducing mechanical stress on organs during physiological activities like and , maintaining organ positioning, and providing a protective cushion within the ventral body cavities. Prominent examples of serous membranes include the pleura, which lines the thoracic cavities and covers the lungs; the pericardium, which encloses the heart within the mediastinum; and the peritoneum, which lines the abdominopelvic cavity and wraps abdominal organs such as the stomach and intestines. These structures are derived from mesoderm during embryonic development and are essential for the integrity of the body's internal environment, with disruptions such as excessive fluid accumulation (effusions) potentially leading to clinical issues like organ compression.

Overview

Definition

A serous membrane, also known as a serosa, is a thin, double-layered structure that lines the closed body cavities of the thoracic and abdominopelvic regions, providing a protective covering for internal organs without communicating directly with the external environment. These membranes consist of a called overlying a thin layer of , forming both parietal and visceral layers that enclose a filled with . The parietal layer adheres to the cavity walls, while the visceral layer drapes over the organs, allowing smooth movement during physiological activities. Serous membranes are distinct from other types of body membranes, such as mucous membranes, which line cavities open to the exterior like the respiratory and digestive tracts and secrete for protection and lubrication, and synovial membranes, which line joint cavities and produce to reduce in movable joints. Unlike these, serous membranes secrete a watery that minimizes between opposing surfaces in closed cavities, maintaining a sterile environment isolated from external exposure. The term "serous" originates from the Latin word , meaning whey or a watery fluid, reflecting the thin, clear secretion produced by these membranes to lubricate and protect enclosed structures. This nomenclature highlights their primary role in facilitating low-friction interactions within the body's ventral cavities.

Functions

Serous membranes primarily function to secrete a thin layer of that lubricates the surfaces between organs and the walls of surrounding body cavities, thereby reducing friction during physiological movements such as cardiac contractions and respiratory expansions. This is essential for enabling smooth visceral sliding without abrasion or , which could otherwise impair organ function. The , composed mainly of water, electrolytes, and proteins, is produced by the mesothelial cells of the membrane and maintains a delicate balance through continuous and reabsorption. In addition to lubrication, serous membranes act as a protective barrier by sealing off body cavities, which helps prevent the spread of or from one organ to adjacent structures. They also facilitate the suspension and positioning of organs through attachments to underlying connective tissues, providing structural support that anchors viscera in their proper anatomical locations while allowing necessary mobility. These membranes contribute to by absorbing excess to avoid accumulation that could lead to conditions like effusions, ensuring a stable low-friction environment within the cavities. This regulatory mechanism supports overall organ protection and efficient physiological processes.

Anatomy

Layers

Serous membranes are composed of two distinct layers: the parietal layer, which lines the internal surfaces of the body cavity walls, and the visceral layer, which directly covers the surfaces of the organs housed within those cavities. The parietal layer adheres firmly to the cavity walls, such as the in the , and is supported by a thicker underlying layer of that provides structural reinforcement. In contrast, the visceral layer is thinner, more delicate, and highly mobile, enabling it to closely conform to the irregular contours of the organs it envelops while facilitating their movement. These layers form a serous as a between them, containing only a minimal volume of —typically ranging from 5 to 50 mL depending on the specific —which acts as a to reduce and allow independent motion of the organs relative to the cavity walls without or . The vascular supply differs between the layers: the parietal layer receives blood from the vessels of the adjacent body wall, such as intercostal or arteries, while the visceral layer is nourished by the arterial supply of the organs it covers, like bronchial arteries for pulmonary structures. Both layers are innervated to transmit sensory information, including sensations; the parietal layer via (e.g., intercostal and phrenic) for localized , and the visceral layer through autonomic and visceral afferents for more diffuse referral.

Specific Membranes

The pericardium is a serous membrane that surrounds the heart and the roots of the great vessels within the mediastinum of the thoracic cavity. It is composed of an outer fibrous layer for structural support and an inner serous layer that facilitates smooth cardiac motion. The pleura forms a pair of serous membranes in the thoracic cavity, one enveloping each lung while the other lines the internal thoracic walls. The parietal pleura comprises the costal portion adjacent to the ribs, the diaphragmatic portion overlying the diaphragm, and the mediastinal portion facing the central mediastinum. The represents the most extensive serous membrane, lining the walls of the and covering the majority of abdominal viscera to create peritoneal folds and ligaments. Key extensions include the , a prominent double-layered apron-like fold descending from the greater curvature of the over the intestines, and the , which connects the lesser curvature of the and proximal to the liver. The is a serous membrane located in the , partially enclosing the testes and as a derivative of the peritoneal extension during testicular . It consists of parietal and visceral layers that form a around these structures. Congenital variations in serous membranes, such as anomalous peritoneal bands, can arise from incomplete or aberrant intestinal during embryonic , potentially forming abnormal adhesions between peritoneal folds and viscera. These bands are typically incidental but may alter the normal anatomical relationships in the . In , serous membranes exhibit variations across ; for instance, while present in mammals, their organization differs in non-mammalian vertebrates, and they are absent in acoelomate lacking a true .

Histology and Physiology

Microscopic Structure

The mesothelium forms the outermost layer of serous membranes and consists of a composed of flattened, nucleated cells arranged in a . These mesothelial cells are typically 2.5 to 3 microns thick and exhibit polygonal shapes when viewed from the surface, contributing to the membrane's smooth, pavement-like appearance under light microscopy. Mesothelial cells demonstrate regenerative capacity, proliferating in response to injury to restore the epithelial lining, as evidenced by increased incorporation during repair processes following asbestos exposure. Additionally, these cells possess phagocytic properties, enabling them to engulf particles such as fibers or apoptotic cells, which supports local immune surveillance and tissue maintenance. Underlying the mesothelium is the submesothelial layer, a thin stratum of that provides structural support and anchorage. This layer contains fibers for tensile strength, fibers for flexibility, fibroblasts responsible for matrix synthesis and remodeling, and macrophages that contribute to and debris clearance. The thickness of the submesothelial layer varies regionally, generally ranging from a few micrometers to several hundred micrometers, depending on the specific serous membrane and its mechanical demands. At the ultrastructural level, examined via electron microscopy, mesothelial cells display specialized features that enhance their barrier and secretory roles. The apical surface bears numerous long microvilli, which increase surface area for interaction with the overlying and aid in . Intercellular tight junctions seal adjacent cells, preventing paracellular leakage and maintaining the membrane's impermeability, while desmosomes provide mechanical adhesion. A prominent , consisting of reticular and glycoproteins, underlies the cells and interfaces with the submesothelial , ensuring stable attachment. Structural differences exist between the parietal and visceral components of serous membranes, particularly in the submesothelial layer. The parietal layer, lining body cavities, features a denser submesothelial with more compact arrangement of and fibers, promoting firm adherence to underlying walls. In contrast, the visceral layer, enveloping s, has a looser submesothelial matrix that allows greater flexibility and smoother conformance to contours during . These adaptations reflect the distinct environments of each layer.

Serous Fluid Composition

Serous fluid is primarily an ultrafiltrate of , consisting of approximately 99% along with electrolytes such as sodium (Na⁺) and (Cl⁻) ions that closely match concentrations, typically around 140-150 mEq/L for Na⁺ and 100-110 mEq/L for Cl⁻. The protein content is low, ranging from 1 to 2 g/dL, predominantly composed of , which contributes to the fluid's oncotic properties without significantly increasing . Additionally, trace amounts of are present, aiding in lubrication by enhancing the fluid's ability to reduce friction between serous membrane layers. The production of serous fluid involves active secretion by mesothelial cells lining the serous membranes, facilitated through aquaporins for water transport and ion channels such as epithelial sodium channels (ENaC) for electrolyte movement, resulting in a net turnover rate of approximately 0.01 mL/kg/h (about 0.5-1 mL/h for smaller cavities like pleural and pericardial in adults), varying by cavity with higher rates in the peritoneal space (up to ~40 mL/h). This secretion occurs alongside passive from adjacent capillaries, ensuring a steady supply to maintain membrane . Physically, serous fluid appears clear and slightly viscous, with a pH of 7.6-7.8, specific gravity of 1.010-1.015, and around 0.001 Pa·s, properties that enable low and effective during organ movement. Its volume is regulated by hydrostatic pressure gradients across the walls, balanced by oncotic forces and efficient lymphatic drainage, primarily through parietal stomata, to prevent accumulation or depletion. This supports the fluid's role in minimizing , as detailed in the functions of serous membranes.

Embryological Development

Origin

Serous membranes derive from the , a subdivision of the mesodermal that forms during in the third week of human embryogenesis. This mesoderm arises from epiblast cells migrating through the and is positioned laterally to the paraxial and . As development proceeds, the undergoes vacuolization, leading to its horizontal splitting into two distinct layers: the dorsal (or parietal) layer, which adheres to the and contributes to the parietal serous membranes, and the ventral (or visceral) layer, which associates with the and forms the visceral serous membranes. This bifurcation occurs toward the end of the third week, around days 21-25, establishing the precursors for the body cavities that will house the serous linings. The , the primitive body cavity, emerges concurrently as isolated vacuoles within the by approximately day 20 of embryogenesis, subsequently coalescing into a continuous cavity by day 23. This is lined by the mesodermal layers, which differentiate into a simple squamous —the epithelial component of serous membranes—while the underlying forms the submesothelial layer. The layer lines the coelom's outer walls, giving rise to parietal mesothelium, whereas the layer invests visceral organs, forming visceral mesothelium. Genetic regulation plays a crucial role in mesothelial specification and regional patterning. The Wilms tumor 1 gene (WT1) is expressed in the coelomic epithelium from early stages, marking and directing the of mesothelial progenitors in structures such as the , pleura, and . WT1 promotes the epithelial identity of and contributes to lineage tracing in visceral and parietal layers across models. , particularly those in paralogous groups like Hox9 and Hox10/11, provide anteroposterior positional cues to the , influencing regional identity and ensuring proper segmentation of serous cavity precursors, such as in and limb-associated patterning. In comparative , the formation of serous membranes from a closed lined by is conserved among vertebrates, reflecting shared developmental mechanisms from chordate ancestors. However, non-mammalian like exhibit variations, featuring an open hemocoel rather than discrete serous cavities; this space lacks a continuous mesothelial lining and instead consists of a hemolymph-filled compartment bordered directly by basal laminae.

Formation Process

The formation of serous membranes begins during the fourth week of embryonic development with the expansion of the , a fluid-filled arising from within the . This is initially a continuous, horseshoe-shaped space bounded laterally by the somatopleure (somatic mesoderm lined by , which will form the parietal layer of serous membranes) and medially by the splanchnopleure (splanchnic mesoderm associated with , destined to become the visceral layer). As the embryo undergoes cephalocaudal and lateral folding, the separates into distinct intraembryonic and extraembryonic portions, establishing the foundational spaces for the future pericardial, pleural, and peritoneal . Between weeks 5 and 7, partitioning of the occurs through the growth of mesenchymal , creating separate serous cavities. The pleuropericardial folds migrate ventrally to divide the cranial portion of the into the pericardial cavity (ventral to the ) and paired pleural cavities, while the pleuroperitoneal folds and extend dorsally to separate the pleural cavities from the caudal , forming the . These folds, derived from somatic mesoderm, fuse with contributions from the esophageal and chest wall to establish impermeable boundaries between the cavities. A key event in peritoneal formation is the incorporation of the endoderm-lined gut tube into the visceral layer via dorsal and ventral mesenteries, which anchor the gut within the splanchnopleure-derived . Additionally, by week 9, an evagination of the known as the processus vaginalis extends through the during the initial phase of testicular , forming the as a serous sac with parietal and visceral layers enveloping the anterior testis. Disruptions in this partitioning process can lead to anomalies, such as congenital , which arises from incomplete fusion or expansion of the pleuroperitoneal folds during weeks 4 to 8, resulting in persistent communication between the pleural and peritoneal cavities and allowing abdominal organs to herniate into the . The full establishment of serous cavities is typically achieved by the end of the first , although mesothelial cell maturation and fine-tuning of membrane layers continue into the second .

Clinical Aspects

Associated Diseases

Serous membranes are susceptible to various pathological conditions that directly affect their mesothelial lining and function. These include malignant neoplasms, inflammatory processes leading to fluid accumulation or adhesions, and rarer benign proliferations. is a malignant tumor arising from the of serous membranes, most commonly the pleura, and is strongly associated with prior exposure in over 80% of cases. The disease exhibits a long latency period of 20-60 years following exposure. Histologically, it presents in subtypes including epithelioid (most common and better prognosis), sarcomatoid (more aggressive), and biphasic (mixed). Pleural predominates, accounting for approximately 75% of cases, often manifesting with dyspnea and due to tumor encasement of the . Serous effusions involve the abnormal accumulation of fluid within serous cavities, such as pleural, peritoneal, or pericardial spaces, disrupting normal membrane lubrication and leading to organ compression. For instance, pleural effusions commonly arise from , resulting in transudative fluid due to increased . Effusions are classified as transudative (low protein content, <3 g/dL, from systemic imbalances like hypoalbuminemia or portal hypertension) or exudative (high protein, >3 g/dL, from local or increasing ). Exudative examples include those secondary to or , where inflammatory mediators promote fluid leakage across the . Peritonitis refers to inflammation of the , a serous membrane lining the , often triggered by bacterial contamination from gastrointestinal perforation in acute cases, such as or . Chronic peritonitis frequently complicates , where repeated use introduces pathogens, leading to recurrent episodes and progressive membrane sclerosis. The inflammatory response in peritonitis promotes deposition, resulting in fibrinous adhesions that can cause or by tethering organs.

Diagnostic and Therapeutic Considerations

Diagnosis of serous membrane disorders often begins with imaging modalities to detect effusions and assess underlying . Computed tomography () and (MRI) are primary tools for identifying pleural and peritoneal effusions, providing detailed visualization of fluid accumulation and membrane involvement. (), particularly when combined with (), aids in staging malignant pleural by detecting metabolic activity in tumors, with high sensitivity for identifying malignant involvement in serous cavities. Fluid analysis from serous effusions is crucial for differentiating transudative from exudative processes. Light's criteria classify an effusion as exudative if the pleural fluid protein-to-serum protein ratio exceeds 0.5, the pleural fluid -to-serum LDH ratio exceeds 0.6, or the pleural fluid LDH is greater than two-thirds the upper limit of normal for serum LDH; these thresholds exhibit high sensitivity (98%) for detecting exudates. Biopsy procedures, such as for pleural effusions or for peritoneal involvement, allow for cytological examination and histopathological confirmation of disorders like . Therapeutic management of serous membrane disorders emphasizes symptom relief and disease control. For recurrent pleural effusions, drainage via insertion followed by chemical using slurry is effective, achieving success rates of 80-95% in obliterating the pleural space and preventing reaccumulation, particularly in malignant cases. In malignant pleural , first-line systemic therapy as of 2025 includes combinations such as nivolumab plus , which have demonstrated improved overall survival compared to alone in clinical trials. regimens, such as pemetrexed plus (with or without ), remain options, particularly for patients ineligible for , with historical trials showing median survival of 12.1 months versus 9.3 months for alone and response rates of 41.3% versus 16.7%. may be adjunctive for local control, while surgical interventions like peritonectomy in for involve systematic stripping of tumor-affected to maximize resection, often combined with . Emerging approaches include targeted therapies and biomarkers for improved outcomes. Anti-vascular endothelial growth factor () agents, such as , target in serous membrane tumors like peritoneal malignancies, enhancing vascular normalization and response when combined with in recurrent cases. mesothelin serves as a for early detection of malignant pleural , with elevated levels offering diagnostic utility in asbestos-exposed individuals prior to overt disease. Prognostic factors for serous membrane disorders, particularly , are stage-dependent, with overall 5-year relative survival at 15%; localized disease yields 23%, while distant spread reduces it to 11%. Median overall survival for advanced pleural mesothelioma treated with or ranges from 14.1 to 18.1 months, influenced by resectability and treatment response.

References

  1. [1]
    1.9: Serosa (Serous Membranes) - Biology LibreTexts
    Jun 4, 2025 · The ventral body cavities are enclosed inside serous membranes (serosa) that line the cavities and the organs inside them and create fluids ...
  2. [2]
    Serous Membrane - an overview | ScienceDirect Topics
    A serous membrane is defined as a thin membrane consisting of a single layer of squamous epithelium (mesothelium) that lines body cavities and organs, ...
  3. [3]
    Anatomical Terminology – Anatomy & Physiology - UH Pressbooks
    A serous membrane (also referred to a serosa) is one of the thin membranes that cover the walls and organs in the thoracic and abdominopelvic cavities. The ...
  4. [4]
    [PDF] Serous Membranes & Cavities
    A serous membrane consists of a single layer of flattened mesothelial cells applied to the surface of a thin layer of collagenous tissue that attaches to ...
  5. [5]
    Serous Membrane | Harvard Catalyst Profiles
    A thin lining of closed cavities of the body, consisting of a single layer of squamous epithelial cells (MESOTHELIUM) resting on a thin layer of CONNECTIVE ...
  6. [6]
    [PDF] Anatomy Lecture Notes Section 1: Tissue Membranes in the Body
    Like serous membranes, synovial membranes line cavities that do not open to the outside. However, unlike serous membranes, they do not have a layer of.
  7. [7]
    [PDF] GLOSSARY of HISTOLOGICAL & MICRO-ANATOMICAL TERMS
    serosa L. serum = whey; a pale fluid; a serous membrane lining body cavities. serous adj. L. = having nature of serum.Missing: etymology | Show results with:etymology
  8. [8]
    [PDF] Appendix A
    Sersus = membrane giving off serum (watery fluid). Serous indicating 'watery' portion. Serratus L. Serratus = notched, or serrated from serra = a saw. The ...
  9. [9]
    Serosa: Anatomy and function | Kenhub
    The serosa is a thin layer of connective tissue that lines some internal body cavities and envelops their organs. Learn more about the serosa at Kenhub!
  10. [10]
    Membranes - SEER Training Modules - National Cancer Institute
    Serous membranes are covered by a thin layer of serous fluid that is secreted by the epithelium. Serous fluid lubricates the membrane and reduces friction and ...<|control11|><|separator|>
  11. [11]
    Serous Membranes - (Anatomy and Physiology I) - Fiveable
    The primary function of serous membranes is to reduce friction and facilitate the smooth movement of organs during various body functions, such as respiration ...
  12. [12]
    Serous Fluid - (Anatomy and Physiology I) - Fiveable
    The production and absorption of serous fluid is carefully regulated to maintain a balance and prevent excessive fluid accumulation. Excess or abnormal ...
  13. [13]
    Explain how serous membranes protect organs from infection | Quizlet
    Serous membranes decrease friction between organs and protect them. They envelop the organs and in the case of inflammation of one organ, serve as a barrier.
  14. [14]
    [PDF] Body Cavities And Membranes
    Likewise, the peritoneal membrane supports the movement and positioning of abdominal organs while facilitating fluid exchange and immune responses. Page 27 ...<|control11|><|separator|>
  15. [15]
    Peritoneum: Anatomy, Function, Location & Definition
    Apr 27, 2022 · Your peritoneum is a serous membrane ... The epithelial cells secrete and absorb fluid, filter out particles and carry blood, lymph and nerve ...
  16. [16]
    Organization of the Body: Serous Membranes Explained - Pearson
    Mar 7, 2024 · Serous membranes contribute to homeostasis by providing a frictionless environment for organ movement. The serous fluid within the serous cavity ...<|control11|><|separator|>
  17. [17]
    Anatomy, Thorax, Lung Pleura And Mediastinum - StatPearls - NCBI
    The outer layer is called the parietal pleura and attaches to the chest wall. The inner layer is called the visceral pleura and covers the lungs, blood vessels ...
  18. [18]
    Anatomy, Abdomen and Pelvis, Peritoneum - StatPearls - NCBI - NIH
    The peritoneum is a serous membrane lining the abdominal cavity, supporting organs, and has two layers: parietal and visceral.
  19. [19]
    Pericardium: Function and Anatomy - Cleveland Clinic
    Your pericardium has two main layers that surround your heart. The inner layer (serous pericardium) is itself made of two layers with pericardial fluid in ...
  20. [20]
  21. [21]
  22. [22]
    Pleura: Anatomy, parts and function - Kenhub
    The outer layer (parietal pleura) attaches to the chest wall. The inner layer (visceral pleura) covers the lungs, neurovascular structures of the mediastinum ...
  23. [23]
    The Peritoneum - Visceral - Parietal - TeachMeAnatomy
    Omentum. The omenta are sheets of visceral peritoneum that extend from the stomach and proximal part of the duodenum to other abdominal organs.
  24. [24]
    Greater and lesser omentum: Location, anatomy, function | Kenhub
    The omenta are the fused peritoneal folds that attach the abdominal organs with one another. There are two omenta: the greater omentum; the lesser omentum.
  25. [25]
    Anatomy, Abdomen and Pelvis: Testes - StatPearls - NCBI Bookshelf
    The visceral or inner layer of the tunica vaginalis is close to the epididymis, testes and vas deferens.
  26. [26]
    Tunica vaginalis testis - e-Anatomy - IMAIOS
    It is a pouch of serous membrane, derived from the saccus vaginalis of the peritoneum, which in the fetus preceded the descent of the testis from the abdomen ...
  27. [27]
    Anomalous peritoneal band connecting greater omentum to ... - NIH
    Anomalous peritoneal folds of peritoneum result due to some abnormal events taking place during embryonic development of the gut. They may extend abnormally ...Case Report · Fig. 1 · Fig. 3
  28. [28]
    Small bowel obstruction due to anomalous congenital peritoneal ...
    Background: Congenital bands cause 3 % of all intestinal obstruction and almost always lead to small bowel obstruction. In adults, obstruction due to bands ...
  29. [29]
    The ultrastructure of human abdominal mesothelium - PMC - NIH
    The ultrastructure of human abdominal mesothelium. N J Slater. N J Slater. 1 ... ACTIONS. PDF (5.6 MB); Cite; Collections; Permalink. PERMALINK. Copy. RESOURCES ...
  30. [30]
    Acute injury and regeneration of the mesothelium in response ... - NIH
    The mesothelium is a target of the toxic and carcinogenic effects of asbestos fibers. Fibers greater than 8 mu in length and less than 0.25 mu in diameter ...Missing: histology | Show results with:histology
  31. [31]
    Pleural mesothelial cells in pleural and lung diseases - Batra
    PMCs are phagocytic and produce several cytokines and adhesion molecules (5). Mesothelial cells have microvilli and multiple intercellular adherens junctions as ...
  32. [32]
    Biology of the peritoneum in normal homeostasis and after surgical ...
    Sep 4, 2007 · The submesothelial layer consists of the extracellular matrix made up of different types of collagen, glycoproteins, glycosaminoglycans and ...
  33. [33]
    Physiology of pericardial fluid production and drainage - PMC - NIH
    Pericardial fluid is produced by ultrafiltration and drained mainly by lymphatic capillaries. The fluid volume is determined by the balance between production ...
  34. [34]
    Physiology, Pleural Fluid - StatPearls - NCBI Bookshelf
    The composition of normal pleural fluid consists of total white blood cell count of 1.716 x 10(3) cells mL(-1). Differential cell counts: 75% macrophages, 23% ...Organ Systems Involved · Pathophysiology · Clinical Significance
  35. [35]
    Acid mucopolysaccharide composition of serous effusions. <i>Study ...
    In another study chemical analysis of serous effusions from 14 patients suggested the presence of sulfated acid muco- polysaccharides as well as hyaluronic acid ...
  36. [36]
    Electrolyte and Fluid Transport in Mesothelial Cells - PMC
    Accumulating evidence suggests that the monolayer of mesothelial cells is permeable to electrolyte and fluid, and thereby govern both fluid secretion and re- ...
  37. [37]
    Lateral Plate Mesoderm - Developmental Biology - NCBI Bookshelf
    On either side of the intermediate mesoderm resides the lateral plate mesoderm. Each plate splits horizontally into the dorsal somatic (parietal) mesoderm, ...
  38. [38]
    Mesoderm - UNSW Embryology
    Jul 16, 2019 · The mesoderm forms the middle layer of the early trilaminar embryo germ layers (ectoderm, mesoderm and endoderm) formed by gastrulation.
  39. [39]
    The lateral mesoblast - embryology.ch
    The lateral plate mesoderm is composed of two thick layers that surround a cavity, the intraembryonic coelom (the coelom represents the future serous cavity of ...
  40. [40]
    The intraembryonic coelom | embryology.ch
    The intraembryonic coelom first appears in the lateral plate mesoderm in the form of several isolated vacuoles.
  41. [41]
    Expression of the Wilms' tumor gene WT1 in human ... - PubMed
    WT1 is expressed principally in the fetal kidney, developing gonads, and spleen and also in the mesothelium, which lines the coelomic cavities.
  42. [42]
    Hand2 delineates mesothelium progenitors and is reactivated in ...
    Mar 30, 2022 · Several genes, including Mesothelin (Msln), Gata4, Tbx18, Tcf21, and Wilms Tumor 1 (Wt1), have enabled labeling and genetic lineage tracing of ...
  43. [43]
    Hox Genes and Regional Patterning of the Vertebrate Body Plan
    Thus, it is possible that HoxPG9 modulates the response of the lateral plate mesoderm to the migration signals or the production of the signals themselves ...
  44. [44]
    Comparative Embryology - Developmental Biology - NCBI Bookshelf
    All developing vertebrates appear very similar shortly after gastrulation. It is only later in development that the special features of class, order, and ...
  45. [45]
    A Darwinian approach to the development of the vascular system in ...
    Mar 27, 2025 · The hemocoel is bordered not by mesoderm-derived mesothelial cells, but rather by the basal surface of the tissue cells themselves. Tissues are ...
  46. [46]
    Serous Cavity Formation
    horseshoe-shaped cavity bounded by splanchnopleure and somatopleure • the original space between trophoblast and hypoblast is filled by ...Missing: development | Show results with:development
  47. [47]
    Descent of the testes - embryology.ch
    The lower portion persists as the tunica vaginalis testis, which consists of a parietal and a visceral layer.
  48. [48]
    Diaphragmatic Hernia - StatPearls - NCBI Bookshelf - NIH
    Congenital diaphragmatic hernia primarily arises from the incomplete development of the fetal diaphragm during pregnancy, allowing abdominal organs to ...Missing: septation serous
  49. [49]
    Cellular Origin(s) of Congenital Diaphragmatic Hernia - Frontiers
    Nov 29, 2021 · Mutations in CDH-implicated genes can lead to the incomplete expansion of the PPFs and thus lead to incompletely developed diaphragms that ...<|control11|><|separator|>
  50. [50]
    The Molecular Basis of Malignant Pleural Mesothelioma - PMC - NIH
    Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the pleural lining associated with asbestos exposure in >80% of cases.
  51. [51]
    Malignant pleural mesothelioma: history, controversy and future of a ...
    Mesothelioma has a long latency period: 20–60 years may elapse between asbestos or other oncogenic exposure and the clinical presentation of disease, and the ...
  52. [52]
    Malignant Pleural Mesothelioma: Incidence, Etiology, Diagnosis ...
    The average latency of mesothelioma after asbestos exposure was once thought to be 30 years, but more recent data have led this figure to be revised upward ...
  53. [53]
    Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma
    Aug 20, 2021 · Mesothelioma is a cancer predominantly of the pleural cavity. There is a clear association of exposure to asbestos with a dose dependent risk of mesothelioma.
  54. [54]
    Pleural Effusion - StatPearls - NCBI Bookshelf - NIH
    Aug 31, 2024 · Common causes of transudative pleural effusion include conditions that alter the hydrostatic or oncotic pressures in the pleural space, such as ...Continuing Education Activity · Etiology · Evaluation · Differential Diagnosis
  55. [55]
    Peritonitis - Symptoms and causes - Mayo Clinic
    Aug 8, 2025 · Peritonitis is a serious condition that starts in the abdomen. That's the area of the body between the chest and the pelvis.Missing: adhesions | Show results with:adhesions
  56. [56]
    Peritoneal dialysis-related peritonitis: challenges and solutions - PMC
    Jun 11, 2018 · Peritoneal dialysis-related peritonitis remains the major complication and primary challenge to the long-term success of peritoneal dialysis.Missing: fibrinous | Show results with:fibrinous
  57. [57]
    Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells ...
    Mar 29, 2021 · Besides fibrosis during PD practice, peritoneum is directly implicated in the genesis of post-surgical intra-abdominal adhesions (peritoneal ...
  58. [58]
    A case of ovarian serous cystadenofibroma with scattered lesions in ...
    Sep 6, 2021 · Ovarian serous cystadenofibroma is a relatively rare subtype of serous cystadenoma classified as ovarian benign epithelial tumor.
  59. [59]
    Introduction to the second edition of 'Diagnostic Cytopathology of ...
    Dec 6, 2021 · It consists of a flat monolayer of mesothelial cells, which have a tendency to undergo hypertrophy and hyperplasia secondary to various stimuli, ...
  60. [60]
    Radiological review of pleural tumors - PMC - NIH
    Initial imaging modalities are chest radiography and Computed Tomography (CT). Further characterization may be required using Ultrasoundgraphy (USG), Magnetic ...
  61. [61]
    The role of 18F-FDG PET/CT in patients with serous cavity effusion ...
    May 22, 2025 · 18 F-FDG PET/CT was determined to be an effective imaging modality for detecting undetermined serous cavity effusion, exhibiting high diagnostic performance.
  62. [62]
    Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment ...
    Sep 1, 2025 · Mesothelioma is a rare malignancy originating from the serosal membranes, with the pleura being the predominant site of manifestation. Despite ...
  63. [63]
    Comparison of the Efficacy of Light's Criteria With Serum-Effusion ...
    Aug 11, 2023 · While Light's criteria exhibit high sensitivity (98%) in detecting exudative pleural effusions, the capacity to rule out transudates is ...
  64. [64]
    Pleural Neoplasms—What Could MRI Change? - PMC
    If proven effective, MRI could be used as a non-invasive tool for pleural tumor detection and characterization, with an increase in patients' safety and comfort ...
  65. [65]
    A diagnostic approach for differentiating abdominal tuberculosis ...
    Dec 16, 2019 · Laparoscopy is an important tool in the management of such cases to avoid extended surgery.
  66. [66]
    Pleurodesis - StatPearls - NCBI Bookshelf
    Jan 19, 2025 · Pleurodesis is a procedure that obliterates the pleural space to prevent recurrent pleural effusions, pneumothorax, or persistent pneumothorax.Continuing Education Activity · Introduction · Indications · Technique or Treatment
  67. [67]
    Phase III study of pemetrexed in combination with cisplatin versus ...
    Treatment with pemetrexed plus cisplatin and vitamin supplementation resulted in superior survival time, time to progression, and response rates
  68. [68]
    Management of pseudomyxoma peritonei - PMC - NIH
    PERITONECTOMY PROCEDURE. This fundamental technique requires the removal and stripping of all tumour tissues involving the parietal and visceral peritoneum.
  69. [69]
    Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF ...
    Arguably, anti-vascular endothelial growth factor (anti-VEGF) therapies hold great promise, but their efficacy has been modest.
  70. [70]
    Serum Mesothelin for Diagnosing Malignant Pleural Mesothelioma
    Mesothelin is currently considered the best available serum biomarker of malignant pleural mesothelioma. To examine the diagnostic accuracy and use of serum ...
  71. [71]
    Survival Rates for Mesothelioma | American Cancer Society
    Jun 27, 2025 · Survival rates are often used by doctors as a way to discuss a person's prognosis (outlook). Learn about the survival rates for mesothelioma
  72. [72]
    Malignant Pleural Mesothelioma: A 2025 Update - PMC - NIH
    Feb 5, 2025 · The updated 3-year survival analysis, with a median follow-up of 43.1 months, reveals substantially improved mOS of 18.1 months in the ...Missing: prognosis | Show results with:prognosis